• Hotline +852 3480 8393

Logo
EN
繁中
  • Home
  • About Us
    • Background
    • Immunotherapy in Japan
    • Immunotherapy in Hong Kong
    • Specialist Consultation
  • Immune Cell Therapy
    • What Is Immune Cell Therapy?
    • Dendritic Cell (DC) Therapy
    • Lymphokine-Activated Killer Cell (LAK) Thearpy
    • Natural Killer Cell (NK) Therapy
    • Success Rate
    • Side Effects
    • Fees
  • Doctor
    • Japan
  • Our News
  • Contact Us
  • EN
    • 繁中
Home > Our News > Clinical Reports > Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

  • Cell Mol Immunol
  • 2025-01-17
  • 1698 View

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264306/


Abstract

Dendritic cells are powerful antigen-presenting cells that are essential for the priming of T cell responses. In addition to providing T-cell-receptor ligands and co-stimulatory molecules for naive T cell activation and expansion, dendritic cells are thought to also provide signals for the differentiation of CD4+ T cells into effector T cell populations. The mechanisms by which dendritic cells are able to adapt and respond to the great variety of infectious stimuli they are confronted with, and prime an appropriate CD4+ T cell response, are only partly understood. It is known that in the steady-state dendritic cells are highly heterogenous both in phenotype and transcriptional profile, and that this variability is dependent on developmental lineage, maturation stage, and the tissue environment in which dendritic cells are located. Exposure to infectious agents interfaces with this pre-existing heterogeneity by providing ligands for pattern-recognition and toll-like receptors that are variably expressed on different dendritic cell subsets, and elicit production of cytokines and chemokines to support innate cell activation and drive T cell differentiation. Here we review current information on dendritic cell biology, their heterogeneity, and the properties of different dendritic cell subsets. We then consider the signals required for the development of different types of Th immune responses, and the cellular and molecular evidence implicating different subsets of dendritic cells in providing such signals. We outline how dendritic cell subsets tailor their response according to the infectious agent, and how such transcriptional plasticity enables them to drive different types of immune responses.

Source: Hilligan, Kerry L, and Franca Ronchese. “Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses.” Cellular & molecular immunology vol. 17,6 (2020): 587-599. doi:10.1038/s41423-020-0465-0


Previous:Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment Next:Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

Category

  • News 18

Latest Articles

  • YouTube channel “珍心活” interviews Dr. Yoichi Kat
    2025-08-03
  • Celebrity Host Cheng Tan Shui’s Exclusive Interview with Connie Lam: How to Choose the Right Doctor in Japan for Immunocellular Therapy
    2025-01-10
  • Hong Kong Actor Carlos Chan Accompanies His Mother to Shin-Yokohama Kato Clinic for Immunotherapy, Expresses Gratitude to Dr. Yoichi Kato
    2024-07-03
  • Yoshida Family Donates 12,000 Square Feet of Land to Dr. Yoichi Kato
    2024-04-05
  • がんの先進医療 | 2025 Jan. vol. 56
    2025-04-02
  • Dr. Kato’s New Medical Facility Nears Completion
    2024-01-19
  • Dr. Kato’s Expert Team: Meet the Visionary Scientist Behind the “Magic Lab”
    2023-11-10
  • “Humanity’s Innate Immune Power Surpasses Any Manufactured Drug” – Dr. Yoichi Kato, Pioneer in Immunotherapy
    2023-11-03
  • Japanese Media Interview with a Renowned Physician: “The Current Status of Late-Stage Healthcare in Japan”
    2023-10-27
  • The Key Differences Among DC, LAK, and NK Immunotherapies—and How to Choose
    2023-10-19
  • Dendritic Cell Vaccine Therapy: Insights from Dr. Yoichi Kato, Immunotherapy Specialist
    2023-08-09
  • Japan’s Leading Expert in Immunotherapy: Dr. Yoichi Kato
    2023-07-27
  • Natural Killer Cells in the Immune System: Your Body's First Line of Defense
    2025-10-13
  • Dendritic Cells Immune Response: The Commanders of Your Immune System
    2025-10-13
  • Dendritic Cells: Defining the Commanders of the Immune System and Their Role in Immunotherapy
    2025-10-13
  • Dendritic Cell Therapy Success Rate: An Evidence-Based Analysis
    2025-10-13
  • Dendritic Cell Therapy: An Advanced Cancer Treatment for Stage 4 Patients
    2025-10-13
All Articles
Logo
  • Email:info@asiaimmune.com
  • Tel / WhatsApp:+852 3480 8393
  • Wechat:aicl_hk
  • Office hours:Mon to Fri | 9am to 6pm

Immune Cell Therapy

  • What Is Immune Cell Therapy?
  • Dendritic Cell (DC) Therapy
  • Lymphokine-Activated Killer Cell (LAK) Thearpy
  • Natural Killer Cell (NK) Therapy
  • Success Rate
  • Side Effects
  • Fees

Address

  • Room 1202, 12/F, Hing Wai Building, 36 Queen's Road Central, Central, HK (📍Goolge Map)
  • +852 3480 8393

Copyright © 2026. Designed by Asia Immunotherapy Company Limited.